Common Contracts

PRE-FUNDED warrant To purchase ordinary shares represented by american depositary shares Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals, Ltd. • February 28th, 2023 • Surgical & medical instruments & apparatus

• Company
  Quoin Pharmaceuticals, Ltd.
• Filed
  February 28th, 2023
• Industry
  Surgical & medical instruments & apparatus

THIS PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from QUOIN PHARMACEUTICALS LTD., a corporation incorporated under the laws of Israel (the “Company”), up to [●] ordinary shares, no par value per share (the “Ordinary Shares”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”) represented by [●] American Depositary Shares of the Company (“ADSs,” and the ADSs issuable hereunder, the “Warrant ADSs”), with each ADS representing five thousand (5,000) Ordinary Shares (the “ADS Ratio”). The purchase price of one Warrant ADS under this Wa

PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES ASLAN PHARMACEUTICALS LIMITED

ASLAN Pharmaceuticals LTD • February 24th, 2023 • Pharmaceutical preparations

• Company
  ASLAN Pharmaceuticals LTD
• Filed
  February 24th, 2023
• Industry
  Pharmaceutical preparations

THIS PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (this “Warrant”), issued in the form of uncertificated securities, certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from ASLAN Pharmaceuticals Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), up to [____] Ordinary Shares, nominal or par value $0.01 per share (as subject to adjustment hereunder, the “Warrant Shares”), represented by [____] American Depositary Shares (“ADSs”), each five (5) Ordinary Shares represented by one (1) ADS, as subject to adjustment hereunder (the “Warrant ADSs”). The purchase p

PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES MOLECULAR DATA INC.

Molecular Data Inc. • September 17th, 2021 • Services-business services, nec • New York

• Company
  Molecular Data Inc.
• Filed
  September 17th, 2021
• Industry
  Services-business services, nec
• Jurisdiction
  New York

THIS PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Molecular Data Inc., an exempted company formed under the laws of the Cayman Islands (the “Company”), up to ______ Class A Ordinary Shares, par value US $0.00005 (the “Class A Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”)), represented by _____________ American Depositary Share (“ADSs”), each 3 Class A Ordinary Shares representing one ADS, as subject to adjustment hereunder (the “Warrant ADSs”). The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined

WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES THERAPIX BIOSCIENCES LTD.

Therapix Biosciences Ltd. • May 19th, 2020 • Pharmaceutical preparations

• Company
  Therapix Biosciences Ltd.
• Filed
  May 19th, 2020
• Industry
  Pharmaceutical preparations

THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, Capital Point Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 15, 2021 (the “Initial Exercise Date”) and on or prior to 4 p.m. on May 15, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Therapix Biosciences Ltd., a company organized under the laws of the State of Israel (the “Company”), up to the amount of Ordinary Shares of the Company (the “Warrant Shares”), to be represented by American Depositary Shares (“ADSs”), as subject to certain adjustment hereunder, and the ADSs issuable upon exercise of this Warrant (the “Warrant ADSs”). The aggregate value of ADSs purchasable under this Warrant shall not exceed $ 340,000. The number of Warrant ADSs underlying this Warrant shall be calculated acc